Home
Solutions
Products
Pricing
Resources
Request Demo
Start Free
Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo
StateStorm

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

  • 1315 new people
  • 107 new organizations
  • 1149 new photos
  • 1999 job history records for people in our database
  • 713 education records for people in our database
  • 3184 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
  • 1 new person through the revolving door
  • 132 new policy reports
  • 15 new trips to our privately funded travel database
  • 356 new personal financial disclosures
  • 9208 new press releases
  • 5 new town halls
  • 37 new hearings

Caught Our Eye Rss

» More from Caught Our Eye
» More from our DevBlog

Health Risk Analysis: Technical Adequacy in Three Selected Cases

  Premium   Download PDF Now (171 pages)
Report Type Reports and Testimonies
Report Date Sept. 30, 1987
Report No. PEMD-87-14
Subject
Summary:

GAO evaluated the risk analysis processes used by the Food and Drug Administration (FDA), the Occupational Safety and Health Administration (OSHA), and the Environmental Protection Agency (EPA) to identify possible weaknesses and strengths in the processes.

GAO found that: (1) risk assessment work generally met acceptable technical and scientific criteria; (2) FDA and OSHA did a credible job of reviewing and evaluating available evidence on a hazard; and (3) problems in risk assessment were primarily related to data availability. GAO also found that: (1) there were significant problems in risk management work; (2) FDA and EPA poorly documented the development and evaluation of risk management options and decisionmaking processes; (3) the extent and quality of risk management guidelines varied greatly between and within the agencies; and (4) none of the agencies conducted follow-up evaluations of the regulations to determine if they were achieving the intended risk reduction effects.

« Return to search Government Accountability Office reports

HomeAbout Us Contact UsPrivacy PolicyTerms of UseJoin Us
© LegiStorm
LegiStorm
2101 L St. NW, Suite 300
Washington, DC 20037
(202) 360-4172 / congress@legistorm.com